Trump said that he was proud to say that he has "made sure that this vaccine would be free to all Americans." He further said that his administration has already begun shipping the vaccine to every state and zip code in the country.
The move sets off what will be the largest vaccination campaign in US history -- but it also has global ramifications because it’s a role model to many other countries facing the same decision.
After an eight-hour public hearing on Thursday, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 17 to 4 with 1 abstention to recommend the vaccine developed by Pfizer and its German partner BioNTech.
Bell's palsy is a type of facial paralysis. It is a condition that causes weakness of muscles on one side of the face and muscles drop. This happens because nerves stop working properly. It is usually temporary and is resolved on its own.
Documents related to the development of the Pfizer/BioNTech Covid-19 vaccine were “unlawfully accessed” in a cyber attack on Europe’s medicines regulators, the firms have said. The European Medicines Agency (EMA) confirmed earlier that it had been subjected to a cyber attack but did not provide any details beyond saying a “full investigation” had been launched.
Canada’s health regulator on Wednesday approved Pfizer’s COVID-19 vaccine. Health Canada posted on it is website that the vaccine made by U.S. drugmaker Pfizer and Germany’s BioNTech is authorized.
Pfizer will have differential pricing on its coronavirus vaccine for different countries, as the company aims to make the vaccine available across the world, the global pharma major said on Wednesday.
Pfizer's mRNA technology-based vaccine has an efficacy of over 90 per cent with a double dose and 67 per cent with a single dose. It, however, requires minus 70 degrees Celsius, which does not match India's cold storage facilities.
Britain on Tuesday began vaccinations with the shot made by Pfizer and German partner BioNTech. The FDA later this month will consider one developed by Moderna.
The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, with the UK regulator Medicines and Healthcare products Regulatory Agency (MHRA) granting a temporary authorisation for its emergency use.
After securing a clearance by its parent company in the United Kingdom and Bahrain, Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use authorisation for its COVID-19 vaccine in India.
Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country.
The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, with the UK regulator Medicines and Healthcare products Regulatory Agency (MHRA) granting a temporary authorisation for its emergency use.
The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, with the UK regulator Medicines and Healthcare products Regulatory Agency (MHRA) granting a temporary authorisation for its emergency use.
The Gujarat government has put together the cold chain infrastructure to store and transport COVID-19 vaccine alongwith a system for vaccination and lists of priority beneficiaries, Deputy Chief Minister Nitin Patel said on Saturday.
Bahrain did not say how may vaccines it has purchased, nor when vaccinations would begin. Pfizer later said the details of its sales agreement with Bahrain, including the “timing of delivery and the volume of doses,” was confidential and declined to comment.
Global pharma major Pfizer on Thursday said it remains committed to engaging with the Indian government to explore opportunities to make Pfizer/BioNTech vaccine available in the country. "Right now we are in discussions with many governments around the world and remain committed to engaging with the Government of India and explore opportunities to make this vaccine available for use in the country," a Pfizer spokesperson said in a statement.
Pfizer-BioNTech vaccine for coronavirus on Wednesday was approved by UK, becoming the first country to approve it against COVID-19, paving the way for mass vaccinations against the deadly novel coronavirus from as early as next week. The British regulator, the Medicines and Healthcare products Regulatory Agency’s (MHRA), says the jab, which claims to offer up to 95 per cent protection against COVID-19 illness, is safe for roll-out.
Hours after United Kingdom approved Pfizer coronavirus vaccine for emergency use, UK's country medicine regulator MHRA chief Dr June Raine spoke about the safety of the vaccine amid other concerns.
UK on Wednesday became the first country in the world to approve the Pfizer-BioNTech vaccine for use against COVID-19 and said that it will be rolled out from next week. The vaccine has been authorised for emergency use by the Medicines and Healthcare Products Regulatory Authority (MHRA), ahead of decisions by the US and Europe.
Top News
Latest News
